Tetrazole derivatives
US-2024382468-A2 · Nov 21, 2024 · US
US9795689B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9795689-B2 |
| Application number | US-201314421882-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 10, 2013 |
| Priority date | Sep 11, 2012 |
| Publication date | Oct 24, 2017 |
| Grant date | Oct 24, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides powerful methods and compositions for designing, selecting, fine-tuning and optimizing polymer nanogel and other supramolecular assemblies for various properties including, for example, particle size, density and morphology, guest loading capacity and encapsulation stability, and dynamic release control.
Opening claim text (preview).
The invention claimed is: 1. A method for modifying the release rate of an encapsulated guest in a polymer nanogel host, comprising preparing the polymer nanogel host in an aqueous environment having a kosmotropic or chaotropic agent, wherein the kosmotropic or chaotropic agent is present at a concentration suitable for achieving the desired guest release rate, wherein the polymer nanogel host comprises a block co-polymer having the structural formula: wherein each of R 1 , R′ 1 and R″ 1 is independently a hydrogen, C 1 -C 12 alkyl group, or halogen; each of R 2 , R′ 2 , R″ 2 , R 3 , R′ 3 and R″ 3 is independently a hydrogen, (C 1 -C 16 ) alkyl, (C 1 -C 16 ) alkyloxy, or halogen; each of L 1 , L 2 and L 3 is independently a linking group; each of S 1 , S 2 and S 3 is independently a single bond or a spacer group; W is a hydrophilic group; X is a group comprising a crosslinking moiety; Y is a hydrophobic group; and each of i, j and k is independently a positive number. 2. The method of claim 1 , comprising preparing the polymer nanogel in an aqueous environment having a kosmotropic agent. 3. The method of claim 1 , comprising preparing the polymer nanogel in an aqueous environment having a chaotropic agent. 4. The method of claim 2 , wherein the kosmotropic agent is selected from the group consisting of sulfate (SO 4 2− ), phosphate (PO 4 3− ), hydrogenphosphates (HPO 4 2− ), hydroxide (OH − ), magnesium (Mg 2+ ), calcium (Ca 2+ ), sodium (Na + ), lithium (Li + ), proton (H + ), trialkylamine oxide (R 3 N + O − ), proline, ectoine, glycine betaine, and trehalose. 5. The method of claim 4 , wherein the kosmotropic agent is a sulfate (SO 4 2− ). 6. The method of claim 3 , wherein the chaotropic agent is selected from the group consisting of thiocyanates (SCN − ), dihydrogenphosphates (H 2 PO 4 − ), bisulfates (HSO 4 − ), bicarbonates (HCO 3 − ), iodides (I − ), bromides (Br − ), chlorides (Cl − ), nitrates (NO 3 − ), ammonium (NH 4 + ), cesium (Cs + ), potassium (K + ), guanidinium ((NH 2 ) 3 C + ), tetraalkylammonium (R 4 N + ), and urea. 7. The method of claim 6 , wherein the chaotropic agent is a thiocyanate (SCN − ). 8. The method of claim 2 , wherein the kosmotropic agent is present at a concentration from about 1 mM to about 5 M. 9. The method of claim 3 , wherein the chaotropic agent is present at a concentration from about 1 mM to about 5 M. 10. The method of claim 1 , wherein the polymer nanogel comprises a crosslinked network of polymer molecules and non-covalently encapsulated therein a guest releasable upon partial or complete de-crosslinking of the crosslinked network of polymer molecules. 11. The method of claim 1 , wherein each of R 2 , R′ 2 , R″ 2 , R 3 , R′ 3 and R″ 3 is a hydrogen, and each of R 1 , R′ 1 and R″ 1 is a methyl group. 12. The method of claim 11 , wherein each of L 1 , L 2 and L 3 is 13. The method of claim 11 , wherein W comprises a charged group and/or a zwitterionic group. 14. The method of claim 12 , wherein W comprises wherein p is an integer from about 1 to about 40. 15. The method of claim 12 , wherein Y comprises a hydrocarbon chain. 16. The method of claim 15 , wherein X comprises a disulfide moiety, an acetal moiety and/or an enzyme-sensitive linker. 17. The method of claim 16 , wherein X comprises a disulfide moiety. 18. The method of claim 16 , wherein X comprises an acetal moiety. 19. The method of claim 16 , wherein X comprises an enzyme-sensitive linker.
Centrally acting analgesics, e.g. opioids · CPC title
of esters containing halogen, nitrogen, sulfur, or oxygen atoms in addition to the carboxy oxygen · CPC title
Hydrolysis · CPC title
Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein (oligopeptides having up to five amino acids {A61K47/183}; polyamino acids A61K47/34) · CPC title
Preparation of metal salts or ammonium salts · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.